--- pretty_name: HypoAgent — Statistical Analysis Plan SFT Corpus license: other license_name: mixed-ctgov-public-domain-plus-review language: - en task_categories: - text-generation size_categories: - 10K_::`, e.g. `ctgov_NCT05144607::A_full_plan` | | `study_family_id` | `ctgov:` / `aea:` / `osf:` + registry id — **the grouping key for the split** | | `split` | `train` or `test` | | `task_type` | One of the five tasks below | | `study_design` | 13 values, from `parallel_rct` to `online_experiment` | | `outcome_type` | `continuous`, `binary`, `ordinal`, `count`, `time_to_event` | | `method_family` | Method class the target commits to (`linear model`, `survival`, `ordinal`, …) | | `domain` | 13 values; `clinical` 66.2%, `economics / social science` 25.4%, the rest behavioural and social science | | `difficulty` | `complex` (69.4%) or `standard` | | `quality_score` | 0–100 curation score. Mean 60.1, range 40–95; nothing below 40 was kept | | `challenge_sets` | Pipe-separated evaluation slices this example belongs to | | `injected_flaw` | The specific error planted in a `D_critique` prompt; empty for every other task | | `license` | Source license posture | | `human_review_status` | `auto_pending` (CT.gov) or `license_review` (AEA, OSF) | | `synthetic_or_extracted` | Always `synthesized_from_extracted_structured_facts` | | `source_ids`, `source_urls` | One registry id and one URL per row, pointing back to the original record | ## The five tasks | `task_type` | n | What the model is asked for | |---|---:|---| | `A_full_plan` | 20,940 | The complete 20-section plan | | `B_method_selection` | 11,896 | Pick the primary method and rule out the leading alternatives | | `C_completion` | 8,414 | Name what a partial plan is missing and supply it | | `D_critique` | 6,816 | Find the flaw in a proposed plan and fix it | | `H_alternatives` | 6,097 | A preferred analysis, one alternative, and when to switch | `A_full_plan` targets run to twenty numbered sections: research question, hypothesis, estimand, null/alternative, primary endpoint, analysis units, primary method, why that method, assumptions, diagnostics, effect size, uncertainty, alpha, sample size, missing data, multiplicity, subgroups, sensitivity, decision rule, limitations. Median target length is 2,391 characters; the 95th percentile is 6,705. The 6,816 `D_critique` prompts each carry exactly one deliberately planted error, drawn from nine failure modes that recur in real analysis plans: | Planted flaw | n | | Planted flaw | n | |---|---:|---|---|---:| | `ignores_clustering` | 1,243 | | `ignores_nesting` | 747 | | `ignores_pairing` | 1,029 | | `no_multiplicity_control` | 567 | | `ignores_censoring` | 911 | | `count_as_linear` | 367 | | `ordinal_as_continuous_or_dichotomized` | 879 | | `change_score_no_adjustment` | 227 | | `binary_as_continuous` | 846 | | | | ## How the targets were produced Every assistant response is **synthesized from extracted structured facts**, not copied or paraphrased from source text. The pipeline pulls fields out of the registry record — design, randomization unit, arm count, outcome scale, timing, reported design parameters — and a rule-based reasoning engine keys the method off the combination of *outcome distribution × dependence structure × unit of analysis × estimand × comparison type*. A cluster-randomized trial with a continuous endpoint gets a linear mixed model with a random cluster intercept, plus a sentence explaining that clustering — not the raw participant count — drives precision. A single-arm study with a censored endpoint gets Kaplan-Meier description against a prespecified performance criterion, not a two-sample test. Two consequences follow, and both matter: - **No verbatim source text appears in any target.** Only extracted structured fields are reused, which is what makes the AEA and OSF portions distributable at all. - **These are not real statistical analysis plans.** No trial statistician wrote them. They are internally consistent, design-appropriate plans generated from a rule set. A model trained on them learns correct structure and method selection, not the judgement of an experienced SAP author. Curation ran as hard eligibility (outcome determinable, minimum length, bucket-adaptive quality floor) → `keep_score` ranking → budgeted allocation with source quotas, a per-family cap and a 20% ceiling on any single design. That rebalancing is why non-clinical studies make up 33.8% of these files against 21.4% of the 96k pre-curation pool, and why single-arm designs sit at 13.2% instead of 17.3%. Without it, two-arm clinical RCTs with continuous endpoints would swamp everything else. ## Evaluation slices `challenge_sets` marks examples belonging to a hard slice, so you can score a model on the structures it is most likely to get wrong rather than on the corpus average. Slices overlap; membership is pipe-separated. | Slice | n | Slice | n | |---|---:|---|---:| | `clustered_hierarchical` | 8,563 | `preregistered_nonclinical` | 4,519 | | `flawed_plan_correction` | 6,816 | `unseen_domain_nonclinical` | 4,519 | | `survival_censoring` | 6,236 | `longitudinal_repeated` | 3,156 | | `observational_causal` | 5,539 | `count_outcomes` | 2,232 | | `ordinal_outcomes` | 5,002 | `multiple_testing` | 567 | | | | `industrial_ab_testing` | 219 | ## Sources and licensing | Registry | Examples | Share | Licence posture | |---|---:|---:|---| | [ClinicalTrials.gov](https://clinicaltrials.gov/) | 35,872 | 66.2% | US government public domain | | [AEA RCT Registry](https://www.socialscienceregistry.org/) | 13,772 | 25.4% | Unclear — © MIT/AEA, reuse terms not explicitly open | | [OSF Registries](https://osf.io/registries) | 4,519 | 8.3% | Unclear — content licence not set or not verified | The AEA and OSF portions are what make the corpus non-clinical: economics field and lab experiments, psychology and ecology preregistrations, online A/B tests. They are also the portions with unresolved licence terms, tagged `human_review_status=license_review` on every row. Filter on `license` or `human_review_status` to keep only the public-domain ClinicalTrials.gov subset if your use case needs clean terms. Treat the corpus as **research use**. No verbatim source text is reproduced, but the licence posture of two of the three sources is unresolved rather than permissive. Attribute the underlying registries when you use the corresponding subsets; `source_ids` and `source_urls` resolve every row back to its originating record. ## Example A cluster-randomized ICU study, `ctgov_NCT05144607::A_full_plan`, abridged: **user** ```text STUDY DESCRIPTION Objective: Patient-ventilator asynchronies can occur as a result of a mismatch between neural (patient) and ventilator inspiratory and expiratory phases. [...] The impact of the display of Pmus together with the other ventilator waveforms on the ability of health-care professionals to identify asynchronies has not been tested so far. Domain: clinical / Mechanical Ventilation Complication Design: cluster_randomized (randomized, parallel, masking: none) Population / eligibility: Inclusion Criteria: * Healthcare professionals (physicians and respiratory therapists) who work in intensive care units [...] Intervention/exposure: Muscle Pressure curve (Pmus) Comparator: placebo/standard care Primary outcome: Ability of ICU health care professionals to detect patient-ventilator asynchrony Primary timing: Immediately after the completion of the test sessions Number of groups/arms: 2 Planned enrollment: 105 (actual) Reported design parameters: power 0.9, alpha 0.05 Task: Produce a rigorous, prespecified hypothesis-testing and statistical-analysis plan for this study. ``` **assistant** (sections 6–8 of 20) ```text ## 6. Study and analysis units - Randomization/assignment unit: cluster - Observation unit: participant - Analysis unit: cluster - Dependence structure: Participants within a cluster are correlated (intracluster correlation), so a random cluster intercept is included; ignoring it would understate standard errors and inflate the type I error. ## 7. Primary statistical method Linear mixed model with a random cluster effect. Model: Linear mixed model: outcome ~ treatment (+ baseline, stratification factors) with a random intercept for cluster. Primary test: Fixed-effect test of the treatment term. ## 8. Why the method is appropriate Because randomization is at the cluster level while the outcome is measured on individuals, observations are not independent within clusters. A linear mixed model with a random cluster intercept (or GEE with robust standard errors) propagates the intracluster correlation into the inference so the effective sample size, not the raw participant count, drives precision. ``` Section 14 shows the other half of the design. The record reports 90% power at α = 0.05 with n = 105 but no ICC, so the target does not invent one — it states that the power calculation must match the mixed-model analysis and that a design/analysis mismatch invalidates the nominal power. Unreported inputs are named as prespecification decisions throughout rather than filled in with plausible numbers. ## What this corpus is not - **Not authoritative SAPs.** Synthesized targets, described above. - **Not a benchmark with ground-truth labels.** The `test` split is held-out training-distribution data. Use it to compare models against each other, as the model card does; a target here is a reasonable plan, not the only correct one. - **Not clinically validated.** Nothing here has been reviewed by a trial statistician or a regulator. - **Not multilingual.** English only. For questions, use the repository discussion page.